This report compiles laparoscopic surgery data from peer-reviewed studies, meta-analyses, and market research (2020–2026), covering procedure volumes, adoption rates, clinical outcomes, and market sizing. It is intended to support hospital purchasing and supply planning decisions related to growth in minimally invasive surgery.
Key Takeaways
- Over 13 million laparoscopic procedures are performed each year globally
- The laparoscopic instruments market is valued at $16.8B in 2026, growing at 8.6% annually
- Laparoscopic cholecystectomy shows 84% lower mortality vs. open surgery (meta-analysis of 7.5M patients)
- 96% adoption rate for laparoscopic cholecystectomy in acute cases
- Laparoscopic hysterectomy accounts for ~70% of all hysterectomies
- Ambulatory surgery center market reaches $93.25B in 2026
Laparoscopic Surgery Adoption Rates by Procedure
Adoption rate measures the percentage of eligible cases performed laparoscopically rather than via open surgery. These rates vary significantly across procedure types and reflect where each specialty currently sits on the standardization curve.
| Procedure | Current Adoption Rate | Prior Rate (2013) | Change |
|---|---|---|---|
| Cholecystectomy | 96% | 94% | +2 pts |
| Appendectomy | 95% | 83% | +12 pts |
| Laparoscopic Hysterectomy | ~70% | — | — |
| Adhesiolysis (Small Bowel) | 60% | 42% | +18 pts |
| Bariatric Surgery | ~65% | — | — |
| Colorectal Resection | ~50% | — | — |
| Inguinal Hernia Repair | 18% | 3% | +15 pts |
Key Insights:
- Cholecystectomy (96%) and appendectomy (95%) are now nearly fully standardized, with remaining open procedures representing rare exceptions.
- Inguinal hernia repair is the fastest-growing procedure, up 15 percentage points in a decade, driven mainly by expanded minimally invasive surgical training rather than new devices.
- Updated ACOG guidelines now recommend laparoscopic hysterectomy as first-line when feasible, reinforcing continued growth in adoption and demand for endomechanical supplies.
Clinical Outcomes: Laparoscopic vs. Open Surgery
A 2026 systematic review and meta-analysis in the American Journal of Surgery analyzed 85 studies covering over 7.5 million patients. It provides the largest published comparison of laparoscopic versus open cholecystectomy to date.
| Outcome Metric | Laparoscopic Advantage | Study |
|---|---|---|
| Mortality | 84% lower (RR 0.16) | Am. J. Surgery meta-analysis, 2026 |
| Total Complications | 54% fewer (RR 0.46) | Am. J. Surgery meta-analysis, 2026 |
| Hospital Stay | 4.08 days shorter | Am. J. Surgery meta-analysis, 2026 |
| Wound Infection | 71% lower (OR 0.29) | Avicenna Journal of Medicine, 2024 |
| Major Complications | 65% lower (OR 0.35) | Avicenna Journal of Medicine, 2024 |
| Return to Activity | 18 days faster* | JAMA Surgery, 2024 |
Key Insights:
- An 84% mortality reduction across 7.5M patients indicates a major, not marginal, improvement in surgical safety.
- A 4.08-day shorter hospital stay per cholecystectomy can free ~80 bed-days monthly at a center performing 20 cases per month.
- An 18-day faster return to activity after laparoscopic hysterectomy reduces workforce and payer costs, increasing downstream savings for standardized pathways.
Success and Complication Rates by Procedure Type
Complication profiles and average hospital stays vary significantly across laparoscopic procedures. Higher complication rates and longer stays translate directly to greater per-case supply consumption, which affects inventory depth requirements.
| Procedure | Success Rate | Complication Rate | Avg. Hospital Stay |
|---|---|---|---|
| Cholecystectomy | 95–98% | <5% | 1–2 days |
| Appendectomy | 95%+ | ~5% | 1–2 days |
| Hysterectomy | 92–96% | 8–12% | 2–3 days |
| Bariatric Surgery | 94% | 6% | 1–3 days |
| Colorectal Cancer Resection | 86.7%* | 10–15% | 5–7 days |
| Endometriosis Excision | 80% (fertility) | 8.6% (reoperation) | 1–2 days |
Key Insights:
- Cholecystectomy and appendectomy drive core laparoscopic demand, with <5% complication rates and hospital stays under 2 days, supporting high-volume, predictable instrument use.
- Colorectal resection has the highest complication rate (10–15%), but laparoscopic approaches reduce cancer death risk by 59% and recurrence by 66% vs open surgery (BMC Surgery, 2024).
- Endometriosis excision has an 8.6% reoperation rate, extending supply-demand beyond the initial procedure and requiring more robust inventory planning for repeat cases.
Global Laparoscopic Surgery Market Size by Segment (2026)
The laparoscopic surgery market divides into instruments and devices on one side, and procedure-associated markets on the other. Both segments show strong growth trajectories in 2026.
| Market Segment | 2026 Value | CAGR | Forecast Year |
|---|---|---|---|
| Laparoscopic Instruments (Global) | $16.8 billion | 8.6% | 2035 |
| Laparoscopic Gynecological Procedures | $98.42 billion | 8.15% | 2031 |
| U.S. Minimally Invasive Surgery | $165.89 billion* | 7.66% | 2033 |
| Global Ambulatory Surgery Centers | $93.25 billion | 5.2% | 2030 |
Key Insights:
- The laparoscopic instruments market is growing at an 8.6% CAGR through 2035, with the top five manufacturers holding a 59.4% share, led by Johnson & Johnson at 18.5%, which limits buyer pricing leverage.
- North America accounts for 42.15% of gynecological laparoscopic revenue, while Asia-Pacific leads growth at 10.51% CAGR through 2031, making North America the most mature high-volume market.
- Same-day discharge rates rose from 42% (2023) to 61% (2025), accelerating outpatient migration and increasing demand for faster-turnover disposable supplies in ambulatory settings.
About XS Supply
XS Supply helps hospitals and surgery centers source genuine OEM surgical supplies at 20–40% below standard pricing. The company purchases surplus inventory directly from manufacturers and healthcare facilities, and then makes those same products available to procurement teams without contracts or minimum order requirements.
Contact XS Supply today and discover how much your practice could be saving starting next month.
Start Your Order Now
Request a PDF Copy of This Report
Contact XS Supply today to receive your comprehensive "Laparoscopic Surgery Statistics" report in PDF format.
XS Supply only purchases from hospitals, surgical centers, and other vetted industry vendors. XS Supply does not purchase personal medical supplies from individuals.
Further Reading
- The Role of Medical Surgical Instruments in Minimally Invasive Surgery
- How to Choose the Right Medical Equipment for Your Practice
- Reusable vs. Disposable Surgical Instruments: Key Differences
Sources
- iData Research. "Over 13 Million Laparoscopic Procedures Are Performed Globally Every Year." iData Research. October 2020.
- Global Market Insights. "Laparoscopic Instruments Market Size & Forecast 2026–2035." Global Market Insights, Inc. December 2025.
- Mordor Intelligence. "Laparoscopic Gynecological Procedures Market Size, Share & 2031 Growth Trends." Mordor Intelligence. January 2026.
- Kirkpatrick, J. et al. "The Increasing Use of Minimally Invasive Surgery in Acute General Surgical Conditions." Surgery, Vol. 175, Issue 4. Elsevier, April 2024.
- Delpino, F.M. et al. "Comparison Between Open, Laparoscopic, and Robotic Cholecystectomy: A Systematic Review and Meta-Analysis." American Journal of Surgery, Vol. 257. Elsevier, July 2026.
- "Comparisons of Postoperative Outcomes of Laparoscopic Versus Open Surgery Using Inverse Probability of Treatment Weighting Analysis." BMC Surgery, Vol. 24. Springer Nature, June 2024.
- Fox, Matthew. "Is Minimally Invasive Surgery at an Inflection Point?" American College of Surgeons Bulletin, Vol. 110, Issue 9. ACS, October 2025.
- Grand View Research. "U.S. Minimally Invasive Surgery Market Size Report, 2033." Grand View Research. 2025.
